According to Business Market Insights’ research, the Europe Hemodialysis and Peritoneal Dialysis Market was valued at US$ 25,140.48 million in 2022 and is expected to reach US$ 45,277.56 million by 2028, registering an annual growth rate of 6.3% from 2022 to 2028. Rising prevalence of kidney diseases and increasing cases of diabetes are the critical factors attributed to the market expansion.
Download Sample PDF Copy: https://www.businessmarketinsights.com/sample/BMIRE00025826.
Asahi Kasei Medical Co., Ltd.
B. Braun Melsungen AG
Baxter International Inc.
DaVita Inc.
Dialife SA
Diaverum
Fresenius Medical Care AG & Co KGaA
Nipro Medical Corporation
The increasing incidence of diabetes is a primary driver of the European hemodialysis and peritoneal dialysis market. Diabetes-related kidney damage is a significant complication, leading to kidney failure.1 Specifically, studies indicate that 30% of Type 1 and 10-40% of Type 2 diabetes patients will eventually require dialysis. As diabetes prevalence rises across Europe, so does the demand for life-sustaining dialysis treatments.
Furthermore, technological advancements and innovative features in dialysis equipment are enabling vendors to expand their market reach and attract new customers.2 This continuous improvement in dialysis technology is expected to contribute to a strong compound annual growth rate (CAGR) for the European hemodialysis and peritoneal dialysis market during the forecast period.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
You can see this: https://bmisuryakant.blogspot.com/